Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review)
Yuantao Zhang, Yiyang Shang, Hai Zeng, Ruiling Ning, Xinran Zhang, Dongxu Ao, Jun Cai, Qingqing Ye · 2026
Read Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review) by Yuantao Zhang, Yiyang Shang, Hai Zeng, Ruiling Ning, Xinran Zhang, Dongxu Ao, Jun Cai, Qingqing Ye (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13554948.txt.
Description
Yuantao Zhang and co-workers review lactate metabolism in lung cancer, in a 2026 paper. Lactate was once seen as a waste product of tumor sugar burning. It is now known to act as a signal that reshapes the tumor surroundings and helps cancers resist treatment.
Tumors produce and move lactate abnormally, which acidifies their surroundings and promotes invasion and stem-like traits. Lactate also drives chemical marks on proteins that reprogram gene activity. The review links lactate to resistance against chemotherapy, targeted drugs, immune therapy, and radiation. Key enzymes and transporters are presented as control points and possible drug targets.
Catalog record
| CREATOR | Yuantao Zhang, Yiyang Shang, Hai Zeng, Ruiling Ning, Xinran Zhang, Dongxu Ao, Jun Cai, Qingqing Ye |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |